Kivimae, Saul,Hennessy, Marlene,Anand, Neel K.,Cai, Haiying,Deng, Bo-Liang,Ren, Zhongxu,Joshi, Bhalchandra V.
申请号：
AU2018261102
公开号：
AU2018261102A1
申请日:
2018.05.02
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
Provided is a method of administering to a patient having cancer: (a) a 4-1BB agonist； (b) an IL-2Rβ-activating amount of a long-acting, IL-2Rβ-selective agonist； and/or (c) a toll-like receptor agonist, as well as related compositions, kits and compositions.
